WA
DXCM icon

Winfield Associates’s DexCom DXCM Stock Holding History

Winfield Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-120
Closed -$2K – 275
2017
Q4 		$2K Buy
120
+20
+20% +$260 ﹤0.01% 656
2017
Q3 		$1K Hold
100
– – ﹤0.01% 677
2017
Q2 		$2K Hold
100
– – ﹤0.01% 679
2017
Q1 		$2K Hold
100
– – ﹤0.01% 583
2016
Q4 		$1K Buy
100
+80
+400% +$1.42K ﹤0.01% 620
2016
Q3 		$0 Hold
20
– – ﹤0.01% 705
2016
Q2 		$0 Buy
+20
New +$341 ﹤0.01% 724

Other funds holding DXCM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Winfield Associates's DXCM Position: Q1 2018 in Review

Winfield Associates sold out of DexCom (DXCM) in Q1 2018, closing a stake of 120 shares — an estimated $2K sold.

Winfield Associates first reported a position in DXCM in Q2 2016 and held it in 7 quarters. The position peaked at $2K in Q4 2017. 276 funds tracked by Wall St. Rank hold DXCM as of Q1 2018.

  • Winfield Associates reported no remaining DexCom position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 120 DexCom shares in Q1 2018, an estimated $2K.
  • Winfield Associates first reported a position in DexCom in Q2 2016 and held it in 7 quarters.
  • Winfield Associates's DexCom position peaked at $2K in Q4 2017.
  • 276 funds tracked by Wall St. Rank held DexCom as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.